Nomad Foods Reports Third Quarter 2024 Financial Results
Balanced growth strategy delivers volume & value gains
Revenue growth of +0.8% with Adjusted EPS +28% YoY to €0.55
Full year 2024 guidance reduced following a temporary ERP disruption
WOKING,
- Reported revenue increased 0.8% to €770 million
- Organic revenue growth of 0.3% with volume growth of 0.7%, despite an approximate 2.5% temporary headwind related to greater than expected ERP disruptions
- Adjusted EBITDA increased 19.0% to €166 million
- Adjusted EPS increased 28% to €0.55
Management Comments
Stéfan Descheemaeker,
He continued, "The results this quarter are impressive given greater than anticipated headwinds related to ERP implementation that we have faced. Our service levels were negatively impacted during the transition but are returning to near normal levels. The impact, however, has caused us to lower our full year organic sales growth outlook. We have also modestly lowered our full year Adjusted EBITDA growth and Adjusted EPS guidance given the lower sales outlook alongside our choice to continue to invest in the business. Our volume growth and market share recovery are accelerating in the fourth quarter, and we have chosen to prioritize fueling the momentum."
Third Quarter of 2024 results compared to the Third Quarter of 2023
- Revenue increased 0.8% to €770 million. Organic revenue growth of 0.3% was driven by favorable volume growth of 0.7%, continuing the improved trends seen in 2Q24 despite an approximate 2.5% temporary headwind related to greater than expected ERP disruptions in certain markets in the quarter. This was offset by price/mix decline of 0.4%.
-
Gross profit increased 14.5% to €248 million. Gross margin increased 390 basis points to 32.3% due to supply chain productivity, positive product mix performance as we invested in our core most profitable Must
Win Battles , and lower than planned promotional investment as we curtailed in-market support to manage inventory during our ERP transition. - Adjusted operating expenses increased 6.8% to €107 million due to the ongoing investments in capabilities development, and some inflationary headwinds.
- Adjusted EBITDA increased 19.0% to €166 million due to the aforementioned factors.
- Adjusted Profit for the period increased 22% to €89 million, and as a result, Adjusted EPS increased by €0.12 to €0.55. Reported EPS decreased €0.02 to €0.44.
First Nine Months of 2024 results compared to the First Nine Months of 2023
- Revenue increased 1.0% to €2,306 million. Organic revenue growth of 0.3% was driven by favorable price/mix of 0.4%. Volume decline moderated to 0.1%.
-
Gross profit increased 6.3% to €692 million. Gross margin increased 150 basis points to 30.0%, due to a positive product mix performance as we invested behind our core most profitable Must
Win Battles , and improved supply chain productivity. - Adjusted operating expenses increased 11.2% to €335 million due to the planned increase in A&P investments, ongoing investments in capabilities development, and some inflationary headwinds.
- Adjusted EBITDA increased 2.3% to €428 million due to the aforementioned factors.
- Adjusted Profit for the period remained unchanged at €222 million, however, Adjusted EPS increased by €0.07 to €1.36 due to a lower share count. Reported EPS increased €0.11 to €1.08.
2024 Guidance
For the full year 2024, the Company now expects organic revenue growth of 1%-2%, versus the 3-4% prior guidance, due largely to ERP related headwinds faced in 3Q as well as more conservative growth assumptions for the remainder of the year. Management now expects Adjusted EBITDA to grow in a 3%-5% range, versus the +4%-6% prior range, and Adjusted EPS of €1.72-€1.77, implying growth of 7-10% compared to its prior expectation of €1.75-€1.80. The Company continues to expect full year cash flow conversion in the range of 90% to 95%.
Conference Call and Webcast
The Company will host a conference call with members of the executive management team to discuss these results today,
Enquiries
Investor Relations Contact
investorrelations@nomadfoods.com
Media Contact
elaine.mccrimmon@nomadfoods.com
About
Non-IFRS Financial Information
Adjusted financial information for the three and nine months ended
Adjusted EBITDA is profit or loss for the period before taxation, net financing costs, depreciation and amortization, adjusted to exclude, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges and other unusual or non-recurring items. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted EBITDA provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.
Adjusted EBITDA should not be considered as an alternative to profit/(loss) for the period, determined in accordance with IFRS, as an indicator of the Company's operating performance.
Adjusted Profit for the period is defined as profit for the period excluding, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, unissued preferred share dividends, as well as certain other items considered unusual or non-recurring in nature. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted Profit after tax provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.
Adjusted EPS is defined as basic earnings per share excluding, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, as well as certain other items considered unusual or non-recurring in nature. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted EPS provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.
Organic revenue growth/(decline) is an adjusted measurement of our operating results. The comparison for the three and nine months ended
Adjustments for currency translation are calculated by translating data of the current and comparative periods using a budget foreign exchange rate that is set once a year as part of the Company's internal annual forecast process.
Adjusted Free Cash Flow – Adjusted free cash flow is the amount of cash generated from operating activities before cash flows related to exceptional items (as described above), non-operating M&A related costs and working capital movements on employer taxes associated with share based payment awards, but after capital expenditure (on property, plant and equipment and intangible assets), net interest paid, proceeds/(payments) on settlement of derivatives where hedge accounting is not applied and payments of lease liabilities. Adjusted free cash flow reflects cash flows that could be used for payment of dividends, repayment of debt or to fund acquisitions or other strategic objectives.
Cash flow conversion is Adjusted Free Cash Flow as percentage of Adjusted Profit for the period.
Adjusted and Organic non-IFRS financial information should be read in conjunction with the unaudited financial statements of
Please see on pages 8 to 13, the non-IFRS reconciliation tables attached hereto and the schedules accompanying this release for an explanation and reconciliation of the Adjusted and Organic financial information to the most directly comparable IFRS measure. The Company is unable to reconcile, without unreasonable efforts, Organic Growth, Adjusted EBITDA and Adjusted EPS guidance to the most directly comparable IFRS measure.
Nomad Foods Limited As Reported Condensed Consolidated Interim Statements of Profit or Loss (unaudited)
Three months ended
|
|||
|
Three months ended |
|
Three months ended |
|
€m |
|
€m |
Revenue |
769.6 |
|
763.5 |
Cost of sales |
(521.4) |
|
(546.8) |
Gross profit |
248.2 |
|
216.7 |
Other operating expenses |
(111.5) |
|
(104.8) |
Exceptional items |
(14.3) |
|
(13.5) |
Operating profit |
122.4 |
|
98.4 |
Finance income |
1.8 |
|
24.4 |
Finance costs |
(37.2) |
|
(26.4) |
Net financing costs |
(35.4) |
|
(2.0) |
Profit before tax |
87.0 |
|
96.4 |
Taxation |
(16.7) |
|
(18.8) |
Profit for the period |
70.3 |
|
77.6 |
|
|
|
|
Basic and diluted earnings per share in € |
0.44 |
|
0.46 |
Statements of Profit or Loss (unaudited)
Nine months ended
|
|||
|
Nine months ended |
|
Nine months ended |
|
€m |
|
€m |
Revenue |
2,306.4 |
|
2,283.7 |
Cost of sales |
(1,614.5) |
|
(1,632.7) |
Gross profit |
691.9 |
|
651.0 |
Other operating expenses |
(346.2) |
|
(323.2) |
Exceptional items |
(50.2) |
|
(54.1) |
Operating profit |
295.5 |
|
273.7 |
Finance income |
25.7 |
|
21.5 |
Finance costs |
(104.6) |
|
(87.8) |
Net financing costs |
(78.9) |
|
(66.3) |
Profit before tax |
216.6 |
|
207.4 |
Taxation |
(40.9) |
|
(39.4) |
Profit for the period |
175.7 |
|
168.0 |
|
|
|
|
Basic and diluted earnings per share in € |
1.08 |
|
0.97 |
Nomad Foods Limited As Reported Condensed Consolidated Interim Statements of Financial Position
As at
|
|||
|
As at |
|
As at |
|
€m |
|
€m |
Non-current assets |
|
|
|
|
2,105.6 |
|
2,105.0 |
Intangibles |
2,471.0 |
|
2,468.2 |
Property, plant and equipment |
569.5 |
|
563.7 |
Other non-current assets |
7.6 |
|
7.1 |
Derivative financial instruments |
0.2 |
|
0.7 |
Deferred tax assets |
102.1 |
|
106.9 |
Total non-current assets |
5,256.0 |
|
5,251.6 |
Current assets |
|
|
|
Cash and cash equivalents |
334.4 |
|
412.9 |
Inventories |
491.4 |
|
446.4 |
Trade and other receivables |
347.5 |
|
263.4 |
Current tax receivable |
48.8 |
|
40.7 |
Indemnification assets |
0.5 |
|
0.5 |
Derivative financial instruments |
1.4 |
|
1.2 |
Total current assets |
1,224.0 |
|
1,165.1 |
Total assets |
6,480.0 |
|
6,416.7 |
Current liabilities |
|
|
|
Trade and other payables |
742.8 |
|
769.8 |
Current tax payable |
203.2 |
|
189.5 |
Provisions |
25.0 |
|
35.1 |
Loans and borrowings |
26.8 |
|
21.4 |
Derivative financial instruments |
21.4 |
|
12.2 |
Total current liabilities |
1,019.2 |
|
1,028.0 |
Non-current liabilities |
|
|
|
Loans and borrowings |
2,104.6 |
|
2,113.7 |
Employee benefits |
154.6 |
|
158.3 |
Other non-current liabilities |
0.5 |
|
0.5 |
Provisions |
2.8 |
|
1.4 |
Derivative financial instruments |
97.9 |
|
97.8 |
Deferred tax liabilities |
422.2 |
|
425.1 |
Total non-current liabilities |
2,782.6 |
|
2,796.8 |
Total liabilities |
3,801.8 |
|
3,824.8 |
Net assets |
2,678.2 |
|
2,591.9 |
Equity attributable to equity holders |
|
|
|
Share capital and capital reserve |
1,392.2 |
|
1,426.1 |
Share-based compensation reserve |
26.2 |
|
31.4 |
Translation reserve |
121.8 |
|
101.0 |
Other reserves |
(28.9) |
|
(24.6) |
Retained earnings |
1,166.9 |
|
1,058.0 |
Total equity |
2,678.2 |
|
2,591.9 |
Nomad Foods Limited As Reported Condensed Consolidated Interim Statements of Cash Flows (unaudited)
For the nine months ended
|
|||
|
For the nine months ended |
|
For the nine months ended |
|
€m |
|
€m |
Cash flows from operating activities |
|
|
|
Profit for the period |
175.7 |
|
168.0 |
Adjustments for: |
|
|
|
Exceptional items |
50.2 |
|
54.1 |
Share based payment expense |
8.5 |
|
19.8 |
Depreciation and amortization |
71.4 |
|
68.8 |
(Gain)/loss on disposal of property, plant and equipment |
0.2 |
|
1.6 |
Net finance costs |
78.9 |
|
66.3 |
Other operating cash flow adjustments |
0.5 |
|
— |
Taxation |
40.9 |
|
39.4 |
Operating cash flow before changes in working capital, provisions and |
426.3 |
|
418.0 |
Increase in inventories |
(38.5) |
|
(18.6) |
Increase in trade and other receivables |
(84.3) |
|
(32.0) |
Decrease in trade and other payables |
(7.9) |
|
(17.8) |
Decrease in employee benefits and other provisions |
(1.9) |
|
(1.8) |
Cash generated from operations before tax and exceptional items |
293.7 |
|
347.8 |
Cash flows relating to exceptional items |
(55.6) |
|
(46.0) |
Tax paid |
(29.2) |
|
(52.9) |
Net cash generated from operating activities |
208.9 |
|
248.9 |
Cash flows from investing activities |
|
|
|
Purchase of property, plant and equipment and intangibles |
(55.9) |
|
(59.1) |
Interest received |
5.7 |
|
4.1 |
Redemption of investments |
5.7 |
|
0.3 |
Net cash used in investing activities |
(44.5) |
|
(54.7) |
Cash flows from financing activities |
|
|
|
Repurchase of ordinary shares |
(42.9) |
|
(118.4) |
Issuance of new loan principal |
— |
|
6.0 |
Repayment of loan principal |
— |
|
(6.0) |
Payments related to shares withheld for taxes |
(5.2) |
|
(6.7) |
Payment of lease liabilities |
(22.7) |
|
(21.9) |
Dividends paid |
(67.4) |
|
— |
Payment of financing fees |
(2.8) |
|
(1.7) |
Interest paid |
(89.4) |
|
(94.7) |
Net cash used in financing activities |
(230.4) |
|
(252.6) |
Net decrease in cash and cash equivalents |
(66.0) |
|
(58.4) |
Cash and cash equivalents at beginning of period |
399.7 |
|
366.8 |
Effect of exchange rate fluctuations |
0.7 |
|
(2.5) |
Cash and cash equivalents at end of period |
334.4 |
|
305.9 |
Adjusted Financial Information (In € millions, except per share data)
Reconciliation of Non-IFRS Financial Measures
The following table reconciles adjusted financial information for the three months ended
Adjusted Statement of Profit or Loss (unaudited)
Three Months Ended
|
|||||||
€ in millions, except per share data |
As reported for the |
|
Adjustments |
|
|
|
As adjusted for the |
Revenue |
769.6 |
|
— |
|
|
|
769.6 |
Cost of sales |
(521.4) |
|
— |
|
|
|
(521.4) |
Gross profit |
248.2 |
|
— |
|
|
|
248.2 |
Other operating expenses |
(111.5) |
|
4.5 |
|
(a) |
|
(107.0) |
Exceptional items |
(14.3) |
|
14.3 |
|
(b) |
|
— |
Operating profit |
122.4 |
|
18.8 |
|
|
|
141.2 |
Finance income |
1.8 |
|
— |
|
|
|
1.8 |
Finance costs |
(37.2) |
|
5.1 |
|
|
|
(32.1) |
Net financing costs |
(35.4) |
|
5.1 |
|
(c) |
|
(30.3) |
Profit before tax |
87.0 |
|
23.9 |
|
|
|
110.9 |
Taxation |
(16.7) |
|
(4.9) |
|
(d) |
|
(21.6) |
Profit for the period |
70.3 |
|
19.0 |
|
|
|
89.3 |
|
|
|
|
|
|
|
|
Weighted average shares outstanding in millions - basic |
161.4 |
|
|
|
|
|
161.4 |
Basic earnings per share |
0.44 |
|
|
|
|
|
0.55 |
Weighted average shares outstanding in millions - diluted |
161.5 |
|
|
|
|
|
161.5 |
Diluted earnings per share |
0.44 |
|
|
|
|
|
0.55 |
|
|
(a) |
Represents share based payment charge including employer payroll taxes of €4.2 million and non-operating M&A transaction costs of €0.3 million. |
(b) |
Represents exceptional items which management believes are non-recurring and do not have a continuing impact. See Note 6, Exceptional items, within 'Exhibit 99.2 - Condensed Consolidated Interim Financial Statements' for a detailed list of exceptional items. |
(c) |
Elimination of €5.1 million of foreign exchange translation losses. |
(d) |
Represents tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. |
Reconciliation of Non-IFRS Financial Measures (continued)
The following table reconciles adjusted financial information for the three months ended
Adjusted Statement of Profit or Loss (unaudited)
Three Months Ended
|
|||||||
€ in millions, except per share data |
As reported for the |
|
Adjustments |
|
|
|
As adjusted for the |
Revenue |
763.5 |
|
— |
|
|
|
763.5 |
Cost of sales |
(546.8) |
|
— |
|
|
|
(546.8) |
Gross profit |
216.7 |
|
— |
|
|
|
216.7 |
Other operating expenses |
(104.8) |
|
4.6 |
|
(a) |
|
(100.2) |
Exceptional items |
(13.5) |
|
13.5 |
|
(b) |
|
— |
Operating profit |
98.4 |
|
18.1 |
|
|
|
116.5 |
Finance income |
24.4 |
|
(23.0) |
|
|
|
1.4 |
Finance costs |
(26.4) |
|
0.5 |
|
|
|
(25.9) |
Net financing costs |
(2.0) |
|
(22.5) |
|
(c) |
|
(24.5) |
Profit before tax |
96.4 |
|
(4.4) |
|
|
|
92.0 |
Taxation |
(18.8) |
|
— |
|
(d) |
|
(18.8) |
Profit for the period |
77.6 |
|
(4.4) |
|
|
|
73.2 |
|
|
|
|
|
|
|
|
Weighted average shares outstanding in millions - basic |
170.3 |
|
|
|
|
|
170.3 |
Basic earnings per share |
0.46 |
|
|
|
|
|
0.43 |
Weighted average shares outstanding in millions - diluted |
170.3 |
|
|
|
|
|
170.3 |
Diluted earnings per share |
0.46 |
|
|
|
|
|
0.43 |
|
|
(a) |
Represents share based payment charge including employer payroll taxes of €4.4 million and non-operating M&A transaction costs of €0.2 million. |
(b) |
Represents exceptional items which management believes are non-recurring and do not have a continuing impact. See Note 6, Exceptional items, within 'Exhibit 99.2 - Condensed Consolidated Interim Financial Statements' for a detailed list of exceptional items. |
(c) |
Elimination of €17.1 million of net gains on repricing of debt, €5.9 million of foreign exchange translation gains, €0.1 million of interest cost on tax relating to legacy tax audits, as well as €0.4 million of foreign exchange losses on derivatives. |
(d) |
Represents tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. |
Reconciliation of Non-IFRS Financial Measures (continued)
The following table reconciles adjusted financial information for the nine months ended
Adjusted Statement of Profit or Loss (unaudited)
Nine Months Ended
|
|||||||
€ in millions, except per share data |
As reported for the |
|
Adjustments |
|
|
|
As adjusted for the |
Revenue |
2,306.4 |
|
— |
|
|
|
2,306.4 |
Cost of sales |
(1,614.5) |
|
— |
|
|
|
(1,614.5) |
Gross profit |
691.9 |
|
— |
|
|
|
691.9 |
Other operating expenses |
(346.2) |
|
10.9 |
|
(a) |
|
(335.3) |
Exceptional items |
(50.2) |
|
50.2 |
|
(b) |
|
— |
Operating profit |
295.5 |
|
61.1 |
|
|
|
356.6 |
Finance income |
25.7 |
|
(20.1) |
|
|
|
5.6 |
Finance costs |
(104.6) |
|
17.8 |
|
|
|
(86.8) |
Net financing costs |
(78.9) |
|
(2.3) |
|
(c) |
|
(81.2) |
Profit before tax |
216.6 |
|
58.8 |
|
|
|
275.4 |
Taxation |
(40.9) |
|
(12.8) |
|
(d) |
|
(53.7) |
Profit for the period |
175.7 |
|
46.0 |
|
|
|
221.7 |
|
|
|
|
|
|
|
|
Weighted average shares outstanding in millions - basic |
162.5 |
|
|
|
|
|
162.5 |
Basic earnings per share |
1.08 |
|
|
|
|
|
1.36 |
Weighted average shares outstanding in millions - diluted |
162.7 |
|
|
|
|
|
162.7 |
Diluted earnings per share |
1.08 |
|
|
|
|
|
1.36 |
|
|
(a) |
Represents share based payment charge including employer payroll taxes of €10.0 million and non-operating M&A transaction costs of €0.9 million. |
(b) |
Exceptional items which management believes are non-recurring and do not have a continuing impact. See Note 6, Exceptional items, within 'Exhibit 99.2 - Condensed Consolidated Interim Financial Statements' for a detailed list of exceptional items. |
(c) |
Elimination of €14.4 million of net gains on repricing of debt, a one-time €5.7 million gain from the reversal of an impairment of a short-term investment which was made with surplus cash as part of our cash management activities, €17.4 million of foreign exchange translation losses and €0.4 million of losses on derivatives. |
(d) |
Represents tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. |
Reconciliation of Non-IFRS Financial Measures (continued)
The following table reconciles adjusted financial information for the nine months ended
Adjusted Statement of Profit or Loss (unaudited)
Nine Months Ended
|
|||||||
€ in millions, except per share data |
As reported for the |
|
Adjustments |
|
|
|
As adjusted for the |
Revenue |
2,283.7 |
|
— |
|
|
|
2,283.7 |
Cost of sales |
(1,632.7) |
|
— |
|
|
|
(1,632.7) |
Gross profit |
651.0 |
|
— |
|
|
|
651.0 |
Other operating expenses |
(323.2) |
|
21.8 |
|
(a) |
|
(301.4) |
Exceptional items |
(54.1) |
|
54.1 |
|
(b) |
|
— |
Operating profit |
273.7 |
|
75.9 |
|
|
|
349.6 |
Finance income |
21.5 |
|
(17.4) |
|
|
|
4.1 |
Finance costs |
(87.8) |
|
12.7 |
|
|
|
(75.1) |
Net financing costs |
(66.3) |
|
(4.7) |
|
(c) |
|
(71.0) |
Profit before tax |
207.4 |
|
71.2 |
|
|
|
278.6 |
Taxation |
(39.4) |
|
(16.7) |
|
(d) |
|
(56.1) |
Profit for the period |
168.0 |
|
54.5 |
|
|
|
222.5 |
|
|
|
|
|
|
|
|
Weighted average shares outstanding in millions - basic |
172.8 |
|
|
|
|
|
172.8 |
Basic earnings per share |
0.97 |
|
|
|
|
|
1.29 |
Weighted average shares outstanding in millions - diluted |
172.9 |
|
|
|
|
|
172.9 |
Diluted earnings per share |
0.97 |
|
|
|
|
|
1.29 |
|
|
(a) |
Represents share based payment expense including employer payroll taxes of €21.0 million and non-operating M&A transaction costs of €0.8 million. |
(b) |
Exceptional items which management believes are non-recurring and do not have a continuing impact. See Note 6, Exceptional items, within 'Exhibit 99.2 - Condensed Consolidated Interim Financial Statements' for a detailed list of exceptional items. |
(c) |
Elimination of €17.1 million of net gains on repricing of debt, €3.8 million of interest cost on tax relating to legacy tax audits, €7.9 million of foreign exchange translation losses, €1.0 million of losses on derivatives and a €0.3 million gain from the reversal of an impairment loss on a short-term investment. |
(d) |
Represents tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. |
Reconciliation of Non-IFRS Financial Measures (continued)
Reconciliation of Profit for the period to Adjusted EBITDA (unaudited)
|
|||||||
|
Three months ended |
|
Nine months ended |
||||
€ in millions |
|
|
|
|
|
|
|
Profit for the period |
70.3 |
|
77.6 |
|
175.7 |
|
168.0 |
Taxation |
16.7 |
|
18.8 |
|
40.9 |
|
39.4 |
Net financing costs |
35.4 |
|
2.0 |
|
78.9 |
|
66.3 |
Depreciation & amortization |
25.1 |
|
23.2 |
|
71.4 |
|
68.8 |
Exceptional items (a) |
14.3 |
|
13.5 |
|
50.2 |
|
54.1 |
Other add-backs (b) |
4.5 |
|
4.6 |
|
10.9 |
|
21.8 |
Adjusted EBITDA |
166.3 |
|
139.7 |
|
428.0 |
|
418.4 |
|
|
|
|
|
|
|
|
Revenue |
769.6 |
|
763.5 |
|
2,306.4 |
|
2,283.7 |
Adjusted EBITDA margin (c) |
21.6 % |
|
18.3 % |
|
18.6 % |
|
18.3 % |
|
|
(a) |
Adjustment to add back exceptional items. See Note 6, Exceptional items, within 'Exhibit 99.2 - Condensed Consolidated Interim Financial Statements' for a detailed list of exceptional items. |
(b) |
Represents the elimination of share-based payment charges including employer payroll taxes for the three month period to |
(c) |
Adjusted EBITDA margin is calculated by dividing Adjusted EBITDA by Revenue. |
Adjusted Financial Information (continued)
Appendix 1: Reconciliation from reported to organic revenue growth/(decline)
Year on Year Growth -
|
|||
|
Three Months Ended |
|
Nine Months Ended |
|
YoY change |
|
YoY change |
Reported Revenue Growth |
0.8 % |
|
1.0 % |
|
|
|
|
Of which: |
|
|
|
Organic Revenue Growth |
0.3 % |
|
0.3 % |
Translational FX (a) |
0.5 % |
|
0.7 % |
Total |
0.8 % |
|
1.0 % |
|
|
(a) |
Translational FX is calculated by translating data of the current and comparative periods using a budget foreign exchange rate that is set once a year as part of the Company's internal annual forecast process. |
Forward-Looking Statements
Forward-Looking Statements and Disclaimers
Certain statements in this announcement are forward-looking statements which are based on the Company's expectations, intentions and projections regarding its future performance, anticipated events or trends and other matters that are not historical facts, including the Company's expectations regarding (i) its future operating and financial performance, including its reiterated guidance with respect to organic revenue growth, Adjusted EBITDA growth, free cash flow conversion, Adjusted EPS, and Adjusted EPS growth for 2024; (ii) its ability to generate stronger bottom-line growth and superior shareholder returns; (iii) our growth strategy for the fourth quarter, including impacts of the ERP implementation; and (iv) our sales and profit growth and success in 2024 and beyond.
These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including: (i) the Company's ability to effectively mitigate factors that negatively impact its supply of raw materials, including the conflict in
No Offer or Solicitation
This release and referenced conference call is provided for informational purposes only and does not constitute an offer to sell, or an invitation to subscribe for, purchase or exchange, any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance, exchange or transfer of the securities referred to in this press release in any jurisdiction in contravention of applicable law.
The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe such restrictions.
View original content:https://www.prnewswire.com/news-releases/nomad-foods-reports-third-quarter-2024-financial-results-302305583.html
SOURCE